Comparison of the efficacy of the preoperative use of dienogest and gonadotropin releasing hormone agonist for endometriosis: A randomized controlled trial

Comparison of the efficacy of the preoperative use of dienogest and gonadotropin releasing hormone agonist for endometriosis: A randomized controlled trial - The efficacy of the preoperative use of dienogest for endometriosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006469

Enrollment

Registered

2011-11-01

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Dienogest GnRH agonist

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Cases with uni- or bilateral ovarian endometrioma

Exclusion criteria

Exclusion criteria: Case suspected malignant tumor

Design outcomes

Primary

Measure	Time frame
surgical outcomes	—

Countries

Japan

Contacts

Public ContactJun Kumakiri

Juntendo University School of Medicine Obstetrics and Gynecology

kumakiri@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026